Stanford University
Showing 7,261-7,280 of 13,044 Results
-
Mohamad Matout, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Mohamad Matout is a board-certified, fellowship-trained psychiatrist with Stanford Health Care. He is also a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Dr. Matout specializes in using brain stimulation therapies to treat mental illnesses and neurological disorders that do not respond to standard treatments. These therapies include deep brain stimulation (DBS), electroconvulsive therapy (ECT), and transcranial magnetic stimulation (TMS). He serves as the attending psychiatrist for the Youth TMS Clinic at Stanford Health Care, providing transcranial magnetic stimulation for adolescents with treatment-resistant mood disorders. Dr. Matout also uses avatar therapy, an investigational treatment for psychosis that involves using a digital avatar to represent the voices a patient hears.
Dr. Matout’s research centers on brain health as a unifying framework for understanding psychiatric illness across the lifespan. Using a statistical modeling technique called psychometric network analysis, he maps how psychiatric symptoms mutually reinforce or suppress one another. This method reveals the structure of mental illness beyond traditional diagnostic categories. Dr. Matout developed the approach through his graduate work on brain health in HIV and post-COVID syndrome. He now applies it to neuromodulation (changing nerve signals for treatment) and other novel interventions.
Dr. Matout’s two primary lines of research are TMS for adolescents and avatar therapy. He also contributes to a broader range of neuromodulation studies through collaboration with the Brain Stimulation Lab at Stanford University School of Medicine. Beyond his clinical and research work, Dr. Matout is co-founder of AVAtalk Technologies Inc., a mental health technology startup focused on avatar-based therapeutic solutions.
Dr. Matout has authored peer-reviewed publications in Social Psychiatry and Psychiatric Epidemiology, Quality of Life Research, and CEN Case Reports. He has also contributed chapters to Current Medical Diagnosis & Treatment 2027 and Katzung & Trevor's Basic & Clinical Pharmacology (17th ed., McGraw-Hill, in press).
Dr. Matout is a member of the American Neuropsychiatric Association (ANPA) and the Brain Stimulation Society (BraSS), where he serves as assistant treasurer. -
Karen Matthys
Executive Director of the Graduate Program and Strategic Initiatives, Department of Biomedical Data Science - Operations
Current Role at StanfordAs Executive Director in the Department of Biomedical Data Science, Karen leads department strategic initiatives including development of an external partners eco-system. She also manages the graduate degree programs for the department and oversees a team of Student Service Officers.
-
Magdalena Matusiak
Instructor, Pathology
Current Research and Scholarly InterestsMy research focuses on revealing clinically relevant prognostic markers associated with myeloid cell biology.
-
Ted Mau, MD, PhD
Professor of Otolaryngology - Head & Neck Surgery (OHNS)
BioDr. Ted Mau is a board-certified, fellowship-trained laryngologist with Stanford Health Care Ear, Nose, and Throat. He is also a professor in the Department of Otolaryngology – Head & Neck Surgery and chief of the Division of Laryngology at Stanford University School of Medicine. Dr. Mau came to Stanford in 2025 following 17 years at the University of Texas Southwestern Medical Center in Dallas, Texas, where he was director of the Voice Center and vice chair of research for the Department of Otolaryngology – Head and Neck Surgery.
Dr. Mau’s clinical practice focuses on disorders of the voice, airway, and swallowing. He has particular interest in vocal fold and laryngeal lesions, voice problems, vocal fold paralysis, recurrent laryngeal nerve injuries, and laryngeal dystonia. He is an expert in microlaryngeal surgeries, including laser surgeries of the larynx and airway. He also has extensive experience with laryngeal framework surgery for the treatment of vocal fold paralysis, as well as in-office procedures for vocal fold and larynx lesions.
As a physician-scientist, Dr. Mau engages in clinical and laboratory research in voice science and voice disorders. He has served as principal investigator or co-investigator on several National Institutes of Health (NIH)-funded projects, including computational voice simulation, development of ultrafast laser microlaryngeal surgery, sensory contributions to voice disorders, and central neuromodulation as a treatment for recurrent laryngeal nerve injuries. Dr. Mau was a site investigator for a DNA therapeutic vaccine clinical trial for recurrent respiratory papillomatosis. He has served on several NIH study sections.
Dr. Mau served as associate editor of laryngology for The Laryngoscope, a leading journal in the field of otolaryngology. He has published articles in peer-reviewed journals such as the Journal of Voice, The Laryngoscope, and Otolaryngology – Head and Neck Surgery.
Dr. Mau is a fellow of the American Laryngological Association (ALA) and the Triological Society. He is also a member of the American Broncho-Esophagological Association and the secretary of the ALA Council.
